Selective activation of NF-κB subunits in human breast cancer: Potential roles for NF-κB2/p52 and for Bcl-3

Oncogene

Volumn 19, Issue 9, 2000, Pages 1123-1131

  Cogswell, Patricia C ^a   Guttridge, Denis C ^a   Funkhouser, William K ^a,b   Baldwin Jr , Albert S ^a,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Bcl 3; Breast cancer; NF B; NF B2 p52

Indexed keywords

ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN BCL 3; PROTEIN P50; PROTEIN P52; PROTEIN SUBUNIT; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RNA ANALYSIS;

EID: 0034708132     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203412     Document Type: Article

References (48)

1. Arsura M, Wu M and Sonenshein GE. (1996). Immunity, 5, 31-40.
2. Baldwin AS. (1996). Ann. Rev. Immunol, 14, 649-683.
3. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C and Dorken B. (1997). J. Clin. Invest., 100, 2961-2969.
4. Beg AA and Baltimore D. (1996). Science, 274, 782-784.
5. Beg AA, Sha W, Bronson R, Ghosh S and Baltimore D. (1995). Nature, 376, 167-170.
6. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K and Siebenlist U. (1993). Cell, 72, 729-739.
7. Caamano JH, Rizzo CA, Durham SK, Barton DS, Raventos-Suarez C, Snapper CM and Bravo R. (1998). J. Exp. Med., 187, 185-196.
8. Cabannes E, Khan G, Aillet F, Jarrett R and Hay R. (1999). Oncogene, 18, 3063-3070.
9. Carrasco D, Perez P, Lewin A and Bravo R. (1997). J. Exp. Med., 186, 279-288.
10. Chang CC, Zhang J, Lombardi L, Neri A and Dalla-Favera R. (1995). Mol. Cell. Biol., 15, 5180-5187.
11. Chu Z, McKinsey T, Liu L, Gentry J, Malim M and Ballard D. (1997). Proc. Nat. Acad. Sci. USA, 94, 10057-10062.
12. Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville M-P and Bours V. (1995). Oncogene, 11, 1835-1841.
13. Dechend R, Hirano F, Lehmann K, Heissmeyer V, Ansieu S, Wulczyn F, Scheidereit C and Leutz A. (1999). Oncogene, 18, 3316-3323.
14. Dickson RB and Lippman ME. (1995). Endocrine Rev., 16, 559-589.
15. Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ and Baldwin AS. (1997). J. Biol. Chem., 272, 24113-24116.
16. Franzoso G, Carlson L, Scharton-Kersten T, Shores EW, Epstein S, Grinberg A, Tran T, Shacter E, Leonardi A, Anver A, Love P, Sher A and Siebenslist U. (1997). Immunity, 6, 479-490.
17. Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K and Siebenlist U. (1998). J. Exp. Med., 187, 147-159.
18. Fujita T, Nolan GP, Liou HC, Scott M and Baltimore D. (1993). Genes Dev., 7, 1354-1363.
19. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG and Hauser CA. (1996). J. Biol. Chem., 271, 7992-7998.
20. Ghosh S, May MJ and Kopp EB. (1998). Ann. Rev. Immunol., 16, 225-260.
21. Gilmore TD. (1997). J. Clin. Invest., 100, 2935-2936.
22. Guttridge D, Albanese C, Reuther J, Pestell R and Baldwin A. (1999). Mol. Cell. Biol., 19, 5785-5799.
23. Heissmeyer V, Krappmann D, Wulczyn FG and Schedereit C. (1999). EMBO J., 18, 4766-4778.
24. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C and Strauss M. (1999). Mol. Cell. Biol., 19, 2690-2698.
25. Ishikawa H, Carrasco D, Claudio E, Ryseck RP and Bravo R. (1997). J. Exp. Med., 186, 999-1014.
26. Johnson R, Spiegelman B, Hanahan D and Wisdom R. (1996). Mol. Cell. Biol., 16, 4504-4511.
27. Kerr L, Duckett C, Wamsley P, Zhang Q, Chiao P, Nabel G, McKeithan T, Baeuerle P and Verma I. (1992). Genes Dev., 6, 2352-2363.
28. Langer SJ, Bortner DM, Roussel MF, Sherr CJ and Ostrowski MC. (1992). Mol. Cell. Biol., 12, 5355-5362.
29. Liptay S, Schmid RM, Nabel EG and Nabel GJ. (1994). Mol. Cell. Biol., 14, 7695-7703.
30. Liu ZG, Hsu H, Goeddel DV and Karin M. (1996). Cell, 87, 565-576.
31. Mayo MW, Wang C-Y, Cogswell PC, Rogers-Graham KS, Lowe SW, Der C and Baldwin AS. (1997). Science, 278, 1812-1815.
32. McKeithan T, Takimoto G, Ohno H, Bjorling V, Morgan R, Hecht B, Dube I, Sandberg A and Rowley J. (1997). Genes, Chrom. Cancer, 20, 64-72.
33. Michaux L, Dierlamm J, Wlodarska I, Bours V, Van den Berghe H and Hagemeijer A. (1997). Cancer Gen. Cyto., 94, 36-43.
34. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet R and Sledge GW. (1997). Mol. Cell. Biol., 17, 3629-3639.
35. Ong S, Hackbarth M, Degenstein L, Baunoch D, Anastasi J and McKeithan T. (1998). Oncogene, 16, 2333-2343.
36. Ohno H, Takimoto G and McKeithan T. (1990). Cell, 60, 991-997.
37. Resnik JL, Reichart DB, Huey K, Webster NJ and Seely BL. (1998). Cancer Res., 58, 1159-1164.
38. Reuther JY, Reuther GW, Cortez D, Pendergast AM and Baldwin AS. (1998). Genes Dev., 12, 968-981.
39. Schmid RM, Liptay S, Betts JC and Nabel GJ. (1994). J. Biol. Chem., 269, 32162-32167.
40. Schwartz EM, Krimpenfort P, Berns A and Verma IM. (1997). Genes Dev., 11, 187-197.
41. Sherr CJ. (1996). Science, 274, 1672-1677.
42. Sklar MD, Thompson E, Welsh MJ, Liebert M, Harney J, Grossman HB, Smith M and Prochownik EV. (1991). Mol. Cell. Biol., 11, 3699-3710.
43. Sovak MA, Bellas RE, Kim DW, Zanieski G, Rogers A, Traish A and Sonenshein GE. (1997). J. Clin. Invest., 100, 2952-2960.
44. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM. (1996). Science, 274, 787-789.
45. Verma IM, Stevenson JK, Schwartz EM, Van Antwerp D and Miyamoto S. (1995). Genes Dev., 9, 2723-2735.
46. Wang C-Y, Mayo MW and Baldwin AS. (1996). Science, 274, 784-787.
47. Watanabe N, Iwamura T, Shinoda T and Fujita T. (1997). EMBO J., 16, 3609-3620.
48. Zhang Q, DiDonato J, Karin M and McKeithan T. (1994). Mol. Cell. Biol., 14, 3915-3926.